Resources>Upcoming Events>The Antibody Engineering & Therapeutics US

The Antibody Engineering & Therapeutics US

Biointron 2024-06-26

AET US 2024.png

We are excited to announce that Biointron will be participating in the Antibody Engineering & Therapeutics US 2024 conference, taking place from December 15 - 18, 2024, at the Marriott Marquis San Diego, California. We are looking forward to showcasing our latest innovations and connecting with industry professionals. 

Antibody Engineering & Therapeutics US is a premier event that brings together the world’s leading scientists, researchers, and industry experts in antibody research and development. This conference offers a unique platform for sharing cutting-edge research, discussing the latest advancements, and exploring future trends in antibody engineering and therapeutics. Attendees will benefit from an extensive program featuring keynote presentations, interactive sessions, and networking opportunities with top professionals in the field. 

We invite all attendees to visit Biointron’s exhibit to learn more about our pioneering work in antibody engineering. Our team will be available to discuss our latest research, innovative technologies, and how our solutions can support your therapeutic development projects. 

For more details about the event, please visit the Antibody Engineering & Therapeutics US website: [https://informaconnect.com/antibody-engineering-therapeutics/

Time: December 15 - 18, 2024 

Location: Marriott Marquis San Diego | San Diego, CA 

Booth: #109

Subscribe to our Upcoming Events
Explore More Events
Discovery on Target 2025

Time: September 22 - 25, 2025
Location: Boston, MA
Booth: #410

Festival of Biologics Europe 2025

Time: September 30 - October 2, 2025
Location: Basel, Switzerland
Booth: #713

BIO Japan 2025

Time: October 8 - 10, 2025
Location: Yokohama, Japan
Booth: #D63

BIOPLUS INTEPHEX Korea 2025

Time: October 15-17, 2025
Location: Seoul, Korea

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.